Effects of acupuncture to treat fibromyalgia: A preliminary randomised controlled trial
Acupuncture is often used to treat fibromyalgia (FM), but it remains unclear whether acupuncture is effective. This study aims to evaluate the effects of acupuncture on pain and quality of life (QoL) in FM patients.
Sixteen patients (13 women and 3 men aged 25-63 years) suffering from FM were randomised into two groups: group A (n = 8) received five acupuncture treatments after the fifth week and group B received ten acupuncture treatments. Outcome measures used in this study were pain intensity (visual analogue scale, VAS) and the fibromyalgia impact questionnaire (FIQ).
After the fifth week, pain intensity (U = 25.0; P = 0.022) in group B decreased and QoL (U = 24.5; P = 0.026) improved compared to group A.
The present study suggests that acupuncture treatment is effective to relieve pain for FM patients in terms of QoL and FIQ.
KeywordsVisual Analogue Scale Score Acupuncture Treatment Transcutaneous Electrical Nerve Stimulation Fibromyalgia Impact Questionnaire Sham Acupuncture
randomised clinical trial
Quality of Life
visual analogue scale
Fibromyalgia Impact Questionnaire
Complementary and alternative medicine
American College of Rheumatology
transcutaneous electrical nerve stimulation
Fibromyalgia (FM) is a condition of unknown cause; it is characterized by widespread musculoskeltal pain with symptoms including stiffness, fatigue, sleep disturbance and functional impairment [1, 2]. According to the American College of Rheumatology criteria, an FM patient must have chronic widespread pain and at lest 11 out of 18 tender points on examination . Affecting 2-4% of the populations in industrialized countries, FM is the second most common rheumatologic disorder in the world [3, 4]. A wide range of treatment methods are currently in use such as medications, physical methods and manual treatments [5, 6]. Complementary and alternative medicine (CAM) is commonly used to treat FM patients . Ninety-one per cent (91%) FM patients used CAM  and significantly more FM patients used CAM compared to patients of other rheumatologic diseases . One of the most commonly used forms of CAM is acupuncture (annual utilization percentages, from 4.8-6.7% of lifetime experiences to 19.4-26.7% in Japan) . Although acupuncture has been used for pain relief for a long time in China and around the world, studies on the efficacy of acupuncture on FM provided mixed results [1, 11]. Most studies which indicated beneficial effect of acupuncture treatment for FM were uncontrolled case series [1, 11, 12]; only a few supported that acupuncture was effective [1, 13, 14, 15, 16]. A recent systematic review found no evidence to show beneficial effects of acupuncture to treat FM compared with placebo . Although efficacy of acupuncture have been assessed with various controls such as no-treatment controls , non-penetration needling , minimal acupuncture [19, 20] and mock transcutaneous electrical nerve stimulation (TENS) [21, 22], most studies on the efficacy of acupuncture for FM were uncontrolled case series that utilized electroacupuncture treatment [1, 11], which make the setting of controls difficult because it involves perceptible current . One of the alternative ideas which enable evaluation of the efficacy of acupuncture acceptable may be utilization of standard medication as a control condition. The present study aims to determine the efficacy of acupuncture in the symptomatic treatment for FM in comparison to the commonly-used medications.
Participants in the present study were 16 patients who were diagnosed with FM by specialists in respective hospitals and visited Acupuncture and Moxibustion Center, Meiji University of Integrative Medicine (Kyoto, Japan), seeking ways in relieving symptoms. Inclusion criteria were: (1) having met the American College of Rheumatology criteria for the diagnosis of FM for at least one year; (2) widespread pain for six months or more; (3) normal neurological examination findings of nerve function, including deep tendon reflexes, voluntary muscle action and sensory function; and (4) failure to respond to medications prescribed by FM specialists. Exclusion criteria were: (1) sufficient knowledge of acupuncture which may prevent blinding (e.g. having received acupuncture previously); (2) known bleeding diathesis; (3) having autoimmune or inflammatory diseases; (4) participation in other clinical trials; (5) pregnancy or lactation; or (6) receiving disability payments or involved in litigation related to FM. However, patients receiving FM medications were included if there had been no change in their medications for one month or longer prior to recruitment.
Patients having signed a written informed consent were recruited and randomly assigned with a computerised randomisation program (SAMPSIZE V2.0, Blackwell Sience Ltd, UK, permutated block randomization) to either group A where patients received acupuncture treatment followed by a control period or group B where they received continuous acupuncture. This study was approved by the Ethics Committee of Meiji University of Integrative Medicine.
Outcome measures were performed by an independent investigator who was not informed of the treatment sequence or the treatment the patient had received prior to each measurement.
Electroacupuncture and trigger point acupuncture were used to treat the patients. Patients received 15 minutes of electroacupuncture and then 15 minutes of trigger point acupuncture. Four pairs of electrodes were placed on the forearms and lower legs of the patients who were connected to a pulse generator (OhuPulser LFP-4000A, Zen Lryoki Corp, Japan). The current was rectangular with a biphasic top and a frequency of 4 Hz. Intensity of the current was set between the perception and pain thresholds inducing a visible muscular contraction. Disposable stainless steel needles (0.2 mm × 40 mm, Seirin, Japan) were inserted into the skin over the point to a depth of 5-20 mm. Depth of insertion was determined according to the patient's needling sensation of the specific site. Both sides of four common acupuncture points were used for patients receiving electroacupuncture.
Muscles treated in the two trigger point acupuncture groups
The acupuncture was performed by an acupuncturist who had four years of acupuncture training and clinical experience of three or ten years.
Primary outcome measures included pain intensity quantified with a 10 cm visual analogue scale (VAS) and pain disability measured with the fibromyalgia impact questionnaire (FIQ)  on physical function, work, wellbeing. FIQ includes VAS for pain, sleep, fatigue, stiffness, anxiety and depression. Total score ranges between 0-100 with a higher score indicating a negative impact.
The VAS and FIQ measures were completed by the patients immediately before each treatment and analysed immediately before the first treatment (pre), five and ten weeks after the first treatment.
Outcome measures are reported as medians and inter-quartile ranges. Mann-Whitney U test was used to analyse differences between groups at each time period. A difference was considered statistically significant when the P value was less than 0.05. The success of blinding was analysed by Fisher's exact test. Statistical package SYSTAT 12 (SYSTAT Software Inc, USA) was used to perform all the statistical analyses in this study.
Characteristics of patients in the three groups
Pain duration (y)
Two patients in group A and one patient in group B dropped out due to a lack of response to treatments. The dropout rates were not significantly different between the groups (P = 0.52, Fisher's exact test). Analyses were performed on the 13 patients who did complete the study.
Pain intensity VAS scores
Fibromyalgia Impact Questionnaire scores
51.1 (44.0-56.5) *
The present study demonstrated a statistically significant difference between the acupuncture and active control (standard medication) groups five weeks after the first treatment. Moreover, the additionally performed acupuncture treatment after the fifth week in the control group resulted in the further reduction of the FM symptoms. These results suggest that acupuncture treatment is capable of giving additional improvement to the standard medication in the treatment of FM.
The importance of randomised controlled trials (RCT) to study the placebo effect of acupuncture was debated [25, 26]. Acupuncture RCTs with various control methods such as no-treatment controls , non-penetration needling , minimal acupuncture [19, 20] and mock transcutaneous electrical nerve stimulation (TENS) [21, 22] have been carried out. However, positive results were often obtained in studies with a non-acupuncture control [26, 27], whereas negative results tended to be from those with sham acupuncture or mock TENS [28, 29].
Moreover, most studies on the efficacy of acupuncture to treat FM were uncontrolled case series with electroacupuncture treatment [1, 11]. As electroacupuncture involves perceptible current, sham acupuncture as control may not work for electroacupuncture. In fact, Targino et al. reported that addition of acupuncture to usual treatment for FM was beneficial for pain and QoL . Our study also demonstrated that utilization of standard treatment as a control may be an ideal method to evaluate efficacy of acupuncture on FM. Although there were three patients who could not complete the study protocol, we consider the number had not much impact on the results because the numbers of withdrawal were similar between groups (2 out of 8 in group A and 1 out of 8 in group B). One of the limitations of the present study is relatively small sample size. Larger scale studies are required in the future.
The present study suggests that acupuncture treatment is effective to relieve pain for FM patients in terms of QoL and FIQ. Further larger scale clinical trials are warranted to confirm the findings of this study.
The authors wish to thank Dr Y Katsumi and Dr N Ishizaki for his constructive comments on the manuscript and H Ochi and K Ashihara for their assistance during this study.
- 2.Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiectner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, Reynolds J, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 crireria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990, 33: 160-172. 10.1002/art.1780330203.CrossRefPubMedGoogle Scholar
- 7.Branco JC, Saraiva F, Cerinic MM, Zoppi M, Martin N, Taieb C, Myon E: Fibromyaigia syndrome: a European epidemiological survey. Ann Rheum Dis. 2005, 64 (Suppl 3): 1784-Google Scholar
- 10.Ishizaki N, Yano T, Kawakita K: Public status and prevalence of acupuncture in Japan. Evid Based Complement Alternat Med. 2008, doi:10.1093/ecam/nen037Google Scholar
- 14.Harris RE, Tian X, Williams DA, Tian TX, Cupps TR, Petzke F, Groner KH, Biswas P, Gracely RH, Clauw DJ: Treatment of fibromyalgia with formula acupuncture: investigation of needle placement, needle stimulation, and treatment frequency. J Altern Complement Med. 2005, 11 (4): 663-671. 10.1089/acm.2005.11.663.CrossRefPubMedGoogle Scholar
- 20.Harris RE, Zubieta JK, Scott DJ, Napadow V, Gracely RH, Clauw DJ: Traditional Chinese acupuncture and placedo (sham) acupuncture are differentiated by their effects on μ-opioid receptors (MORs). Neuroimage. 2009, 47 (3): 1077-1085. 10.1016/j.neuroimage.2009.05.083.PubMedCentralCrossRefPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.